Nektar Therapeutics (NKTR) Asset Utilization Ratio (2011 - 2026)
Nektar Therapeutics' (NKTR) Asset Utilization Ratio stood at 0.06 in Q2 2026, down 81.8% from 0.32 a year earlier and down 44.9% from the prior quarter.
Powered by 
Analysis
Nektar Therapeutics (NKTR) Asset Utilization Ratio (2011 - 2026) Analysis & Trends
For FY2025, Nektar Therapeutics' Asset Utilization Ratio came in at 0.19, down 32.6% from FY2024.
- Across earlier years, Asset Utilization Ratio came in at 0.28 in FY2024 (+72.5%), 0.16 in FY2023 (+61.4%), 0.10 in FY2022 (+31.3%) and 0.08 in FY2021 (-11.8%).
- The Q2 2026 figure is the lowest quarterly Asset Utilization Ratio since Q4 2019.
- On a year-over-year basis, Asset Utilization Ratio has declined for four consecutive quarters, with an average decline of 4.4% over the last eight quarters.
- Peak year-over-year performance for Asset Utilization Ratio in the last five years was growth of 73.8% in Q4 2023, against a decline of 81.8% in Q2 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at 0.11 (Q1 2026), 0.19 (Q4 2025) and 0.25 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 0.60 |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 0.50 |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 0.47 |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 0.51 |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 0.50 |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 0.41 |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 0.62 |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 0.31 |
| 10 | Nektar Therapeutics | 1.25 Bn | -515.86 Mn | - | 0.06 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.06 |
| Mar 31, 2026 | 0.11 |
| Dec 31, 2025 | 0.19 |
| Sep 30, 2025 | 0.25 |
| Jun 30, 2025 | 0.32 |
| Mar 31, 2025 | 0.31 |
| Dec 31, 2024 | 0.32 |
| Sep 30, 2024 | 0.29 |
| Jun 30, 2024 | 0.25 |
| Mar 31, 2024 | 0.23 |
| Dec 31, 2023 | 0.21 |
| Sep 30, 2023 | 0.19 |
| Jun 30, 2023 | 0.17 |
| Mar 31, 2023 | 0.14 |
| Dec 31, 2022 | 0.12 |
| Sep 30, 2022 | 0.12 |
| Jun 30, 2022 | 0.10 |
| Mar 31, 2022 | 0.10 |
| Dec 31, 2021 | 0.09 |
| Sep 30, 2021 | 0.08 |
API Access
Nektar Therapeutics Asset Utilization Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=NKTR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-utilization-ratio", "ticker": "NKTR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=NKTR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();